background chemotherapy main treatment tripleneg breast cancer nbc lack molecular marker diagnosis therapy cell active chemoresist pathway lead therapeutic failure patient sever kind identify gene howe involve chemoresist full understood method employ kino sina library screen whether target could increase chemosensit cell line effect kind viable various valid atp level colony format protein express phosphorus determine immunoblot genome atlas tca dataset collect analyze correct src prognosis result primary screen valid init hit show potent doxorubicinresist mdash hst inhibitor dasatinib enhance cytotox doxorubicin more akt signal transduc active transcript stat downstream effector accordingly decrease srcsilenc inhibit admit data analysis india level tumor tissue higher tumoradjac normal high express also significantly correct poor concur srcset ai might involve 